SEMA3B and neoplasm: Using MDA-MB435 (breast carcinoma) and A549 (lung adenocarcinoma) cells it was previously shown that SEMA3B suppressed tumor growth but triggered a pro-metastatic program by releasing interleukin 8 [19, 20].